Go to Client Portal
NAMSA

SC5b-9 Complement Activation Assay

Hemocompatibility tests are conducted to evaluate the adverse effects of blood-contacting medical devices or bio-materials on blood or blood components. The effects evaluated include adverse reactions such as thrombosis, hemolysis, platelet, leukocyte, and complement activation, and/or other blood-associated adverse events

Test Options/Variations

V0639-000